JF
RPTX

Jump Financial’s Repare Therapeutics RPTX Stock Holding History

Jump Financial’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,900
Closed -$72.3K – 2053
2024
Q2 		$72.3K Buy
21,900
+9,400
+75% +$33.5K ﹤0.01% 1664
2024
Q1 		$58.9K Sell
12,500
-27,103
-68% -$174K ﹤0.01% 1826
2023
Q4 		$289K Buy
+39,603
New +$222K 0.01% 1362
2023
Q1 		– Sell
-28,000
Closed -$412K – 1989
2022
Q4 		$412K Buy
28,000
+9,800
+54% +$147K 0.02% 863
2022
Q3 		$221K Buy
+18,200
New +$234K 0.01% 1302
2021
Q4 		– Sell
-11,100
Closed -$291K – 1662
2021
Q3 		$291K Buy
+11,100
New +$359K 0.02% 682

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jump Financial's RPTX Position: Q3 2024 in Review

Jump Financial sold out of Repare Therapeutics (RPTX) in Q3 2024, closing a stake of 21,900 shares — an estimated $72.3K sold.

Jump Financial first reported a position in RPTX in Q3 2021 and held it in 6 quarters. The position peaked at $412K in Q4 2022. 56 funds tracked by Wall St. Rank hold RPTX as of Q3 2024.

  • Jump Financial reported no remaining Repare Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 21,900 Repare Therapeutics shares in Q3 2024, an estimated $72.3K.
  • Jump Financial first reported a position in Repare Therapeutics in Q3 2021 and held it in 6 quarters.
  • Jump Financial's Repare Therapeutics position peaked at $412K in Q4 2022.
  • 56 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.